Unique Roles of Phosphorus in Endochondral Bone Formation and Osteocyte Maturation

The mechanisms by which inorganic phosphate (Pi) homeostasis controls bone biology are poorly understood. Here we used Dmp1 null mice, a hypophosphatemic rickets/osteomalacia model, combined with a metatarsal organ culture and an application of neutralizing fibroblast growth factor 23 (FGF‐23) antibodies to gain insight into the roles of Pi in bone biology. We showed (1) that abnormal bone remodeling in Dmp1 null mice is due to reduced osteoclast number, which is secondary to a reduced ratio of RANKL/OPG expressed by osteoclast supporting cells and (2) that osteoblast extracellular matrix mineralization, growth plate maturation, secondary ossification center formation, and osteoblast differentiation are phosphate‐dependent. Finally, a working hypothesis is proposed to explain how phosphate and DMP1 control osteocyte maturation. © 2011 American Society for Bone and Mineral Research.

[1]  L. Bonewald,et al.  The Biological Function of DMP-1 in Osteocyte Maturation Is Mediated by Its 57-kDa C-terminal Fragment , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  M. Fukagawa,et al.  FGF23-parathyroid interaction: implications in chronic kidney disease. , 2010, Kidney international.

[3]  H. Jüppner,et al.  Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. , 2010, Annual review of medicine.

[4]  E. Farrow,et al.  Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets. , 2009, Bone.

[5]  R. Kuroki,et al.  Anti‐FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23 , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  M. Razzaque,et al.  Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone , 2008, PLoS genetics.

[7]  Jian Q. Feng,et al.  Pathogenic role of Fgf23 in Dmp1-null mice. , 2008, American journal of physiology. Endocrinology and metabolism.

[8]  B. Noble,et al.  The osteocyte lineage. , 2008, Archives of biochemistry and biophysics.

[9]  M. Mohammadi,et al.  The parathyroid is a target organ for FGF23 in rats. , 2007, The Journal of clinical investigation.

[10]  R. D'Souza,et al.  Dentin Matrix Protein 1 (DMP1): New and Important Roles for Biomineralization and Phosphate Homeostasis , 2007, Journal of dental research.

[11]  Aditi Gupta,et al.  Emerging role of fibroblast growth factor 23 in a bone–kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization , 2007, Current opinion in nephrology and hypertension.

[12]  M. McKee,et al.  Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo. , 2007, Developmental biology.

[13]  L. Bonewald,et al.  Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism , 2006, Nature Genetics.

[14]  T. Strom,et al.  DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis , 2006, Nature Genetics.

[15]  Xi Jiang,et al.  Pathogenic role of Fgf23 in Hyp mice. , 2006, American journal of physiology. Endocrinology and metabolism.

[16]  Stephen E. Harris,et al.  E11/gp38 Selective Expression in Osteocytes: Regulation by Mechanical Strain and Role in Dendrite Elongation , 2006, Molecular and Cellular Biology.

[17]  B. Hall,et al.  Buried alive: How osteoblasts become osteocytes , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[18]  Hector F Rios,et al.  DMP1 Depletion Decreases Bone Mineralization In Vivo: An FTIR Imaging Analysis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  R. Terkeltaub,et al.  Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. , 2005, The American journal of pathology.

[20]  L. Bonewald,et al.  Dmp1-deficient Mice Display Severe Defects in Cartilage Formation Responsible for a Chondrodysplasia-like Phenotype* , 2005, Journal of Biological Chemistry.

[21]  M. Razzaque,et al.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[22]  Y. Mishina,et al.  Deletion of Dentin Matrix Protein-1 Leads to a Partial Failure of Maturation of Predentin into Dentin, Hypomineralization, and Expanded Cavities of Pulp and Root Canal during Postnatal Tooth Development* , 2004, Journal of Biological Chemistry.

[23]  H. Anderson,et al.  Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. , 2004, The American journal of pathology.

[24]  Y. Takeuchi,et al.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.

[25]  Y. Mishina,et al.  The Dentin Matrix Protein 1 (Dmp1) is Specifically Expressed in Mineralized, but not Soft, Tissues during Development , 2003, Journal of dental research.

[26]  L. Quarles,et al.  Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX* , 2003, Journal of Biological Chemistry.

[27]  R. Cook,et al.  Evidence for the Proteolytic Processing of Dentin Matrix Protein 1 , 2003, Journal of Biological Chemistry.

[28]  Y. Takeuchi,et al.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. , 2002, The Journal of clinical endocrinology and metabolism.

[29]  L. Bonewald,et al.  MLO‐Y4 Osteocyte‐Like Cells Support Osteoclast Formation and Activation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  Jian Q. Feng,et al.  Dentin Matrix Protein 1, a Target Molecule for Cbfa1 in Bone, Is a Unique Bone Marker Gene , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  R. Terkeltaub,et al.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Takeda,et al.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Aubin,et al.  Developmental Expression and Tissue Distribution of Phex Protein: Effect of the Hyp Mutation and Relationship to Bone Markers , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  Michael A. Banks,et al.  Osteoclast Differentiation Requires Ascorbic Acid , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  R. Kumar,et al.  The phosphatonin pathway: new insights in phosphate homeostasis. , 2004, Kidney international.

[36]  M. Mckee,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Osteomalacia in Hyp Mice Is Associated with Abnormal Phex Expression and with Altered Bone Matrix Protein Expression and Deposition* , 2000 .